Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive nonsyndromic deafness that has material basis in variation in the chromosome region 4q12-q13.2.
Features include always present findings: Hearing loss (hearing impairment). 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 2 | Hearing loss (hearing impairment), Abnormal vestibular function |
Age of onset: infancy.
Biomarker and diagnostic research for autosomal recessive nonsyndromic hearing loss 55 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
No clinical trials have been registered for autosomal recessive nonsyndromic hearing loss 55.
10 publications have been identified in PubMed for autosomal recessive nonsyndromic hearing loss 55. Research spans Basic Science / Preclinical (30%), Clinical Trial Publication (20%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 3 | 30% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:30 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Clinical study results |
2 |
20% |
Disease patterns and progression | 2 | 20% |
Testing and diagnosis research | 1 | 10% |
Patient case studies | 1 | 10% |
New treatment approaches | 1 | 10% |
Xun M (2026). [PMID: 41058172](https://pubmed.ncbi.nlm.nih.gov/41058172/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Zaman Q (2025). [PMID: 40404069](https://pubmed.ncbi.nlm.nih.gov/40404069/). *Gene*. [Basic Science / Preclinical]
Long X (2025). [PMID: 40410890](https://pubmed.ncbi.nlm.nih.gov/40410890/). *Hum Genomics*. [Basic Science / Preclinical]
Rezaie N (2024). [PMID: 39614311](https://pubmed.ncbi.nlm.nih.gov/39614311/). *BMC Med Genomics*. [Basic Science / Preclinical]
Hou W (2024). [PMID: 38977330](https://pubmed.ncbi.nlm.nih.gov/38977330/). *Nan Fang Yi Ke Da Xue Xue Bao*. [Diagnostic / Biomarker]
Demirtaş B (2024). [PMID: 39128043](https://pubmed.ncbi.nlm.nih.gov/39128043/). *J Int Adv Otol*. [Case Report / Case Series]
Lv J (2024). [PMID: 38280389](https://pubmed.ncbi.nlm.nih.gov/38280389/). *Lancet*. [Clinical Trial Publication]
D'Arco F (2024). [PMID: 38833161](https://pubmed.ncbi.nlm.nih.gov/38833161/). *Neuroradiology*. [Epidemiology / Natural History]
Parekh B (2024). [PMID: 38833260](https://pubmed.ncbi.nlm.nih.gov/38833260/). *Invest Ophthalmol Vis Sci*. [Epidemiology / Natural History]
Wang H (2024). [PMID: 38839897](https://pubmed.ncbi.nlm.nih.gov/38839897/). *Nat Med*. [Clinical Trial Publication]